Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC).
Meagan A JacobyLaura FinnAshkan EmadiNakhle S SabaBayard L PowellKaren SeiterRosella GarciaStefan FaderlHeather J MalePublished in: Leukemia & lymphoma (2021)